标题
Silencing RORγt in Human CD4+ T cells with CD30 aptamer-RORγt shRNA Chimera
作者
关键词
-
出版物
Scientific Reports
Volume 9, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-07-17
DOI
10.1038/s41598-019-46855-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of novel quinazolinedione derivatives as RORγt inverse agonist
- (2018) Yoshiyuki Fukase et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Structure-based Design and Synthesis of Fluorene Derivatives as Novel RORγ t Inverse Agonists
- (2018) Moustafa T. Gabr et al. CHEMISTRY & BIODIVERSITY
- Discovery of carbazole carboxamides as novel RORγt inverse agonists
- (2018) Yafei Huang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Ixekizumab for the treatment of psoriasis: an update on new data since first approval
- (2018) Christoffer Blegvad et al. Expert Review of Clinical Immunology
- Meta-analysis of the Efficacy and Safety of Secukinumab for the Treatment of Plaque Psoriasis
- (2016) Ju Yeon Ryoo et al. ANNALS OF PHARMACOTHERAPY
- Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease
- (2016) René Pfeifle et al. NATURE IMMUNOLOGY
- Aptamers as targeted therapeutics: current potential and challenges
- (2016) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- The IL-23–IL-17 axis in inflammatory arthritis
- (2015) Erik Lubberts Nature Reviews Rheumatology
- CD4 aptamer–RORγt shRNA chimera inhibits IL-17 synthesis by human CD4+ T cells
- (2014) Pingfang Song et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms
- (2014) Sheng Xiao et al. IMMUNITY
- Pharmacologic Inhibition of ROR t Regulates Th17 Signature Gene Expression and Suppresses Cutaneous Inflammation In Vivo
- (2014) J. Skepner et al. JOURNAL OF IMMUNOLOGY
- Targeting Th17 cells in autoimmune diseases
- (2014) Jianfei Yang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti-Interleukin-17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors
- (2014) Mark C. Genovese et al. Arthritis & Rheumatology
- Pharmacologic Repression of Retinoic Acid Receptor-Related Orphan Nuclear Receptor γ Is Therapeutic in the Collagen-Induced Arthritis Experimental Model
- (2013) Mi Ra Chang et al. Arthritis & Rheumatology
- Identification of SR2211: A Potent Synthetic RORγ-Selective Modulator
- (2012) Naresh Kumar et al. ACS Chemical Biology
- Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
- (2012) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Targeting IL-17 and TH17 cells in chronic inflammation
- (2012) Pierre Miossec et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of Potent and Selective Diphenylpropanamide RORγ Inhibitors
- (2012) Jun R. Huh et al. ACS Medicinal Chemistry Letters
- Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of RORγt Protein
- (2011) Tao Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Basis of Digoxin That Antagonizes RORγt Receptor Activity and Suppresses Th17 Cell Differentiation and Interleukin (IL)-17 Production
- (2011) Saori Fujita-Sato et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras
- (2011) Lee Adam Wheeler et al. JOURNAL OF CLINICAL INVESTIGATION
- Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity
- (2011) Jun R. Huh et al. NATURE
- Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand
- (2011) Laura A. Solt et al. NATURE
- CD30 Ligand/CD30 Plays a Critical Role in Th17 Differentiation in Mice
- (2010) X. Sun et al. JOURNAL OF IMMUNOLOGY
- CD30 Ligand Is a Target for a Novel Biological Therapy against Colitis Associated with Th17 Responses
- (2010) X. Sun et al. JOURNAL OF IMMUNOLOGY
- RORC2 Is Involved in T Cell Polarization through Interaction with the FOXP3 Promoter
- (2010) S. Burgler et al. JOURNAL OF IMMUNOLOGY
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells
- (2009) Peng Zhang et al. LABORATORY INVESTIGATION
- The Benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] Is a Novel Retinoic Acid Receptor-Related Orphan Receptor- / Inverse Agonist
- (2009) N. Kumar et al. MOLECULAR PHARMACOLOGY
- Novel Dual Inhibitory Function Aptamer–siRNA Delivery System for HIV-1 Therapy
- (2008) Jiehua Zhou et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More